Although the molecular aspect of epigenetic changes of SELENBP1 in cancer remains largely unexplored and has not been used clinically in the diagnosis and treatments of patients with cancer yet, the prospects of novel discoveries and potential application of SELENBP1 are promising. The gene discussed is SELENBP1; the disease is cancer.